4.7 Article

Incarcerated Umbilical Hernia of Unexpected Origin: A Primitive Neuroectodermal Tumor With Early Recurrence

期刊

JOURNAL OF CLINICAL ONCOLOGY
卷 32, 期 5, 页码 E3-E6

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/JCO.2012.45.3092

关键词

-

类别

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study

S. Schmid, D. Klingbiel, S. Aeppli, C. Britschgi, O. Gautschi, M. Pless, S. Rothschild, L. Wannesson, W. Janthur, D. Foerbs, I. Demmer, W. Jochum, M. Fruth

LUNG CANCER (2019)

Article Oncology

Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer

Ilaria Alborelli, Katharina Leonards, Sacha Rothschild, Laura P. Leuenberger, Spasenija Savic Prince, Kirsten D. Mertz, Severin Poechtrager, Martin Buess, Alfred Zippelius, Heinz Laubli, Jasmin Haegele, Markus Tolnay, Lukas Bubendorf, Luca Quagliata, Philip Jermann

JOURNAL OF PATHOLOGY (2020)

Article Oncology

Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors: Antibiotics immune checkpoint inhibitors in advanced NSCLC

Anne Schett, Sacha I. Rothschild, Alessandra Curioni-Fontecedro, Stephan Kraehenbuehl, Martin Frueh, S. Schmid, Christoph Driessen, Markus Joerger

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)

Review Oncology

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)

Pavel Dulguerov, Martina A. Broglie, Guido Henke, Marco Siano, Paul Martin Putora, Christian Simon, Daniel Zwahlen, Gerhard F. Huber, Giorgio Ballerini, Lorenza Beffa, Roland Giger, Sacha Rothschild, Sandro Negri, Olgun Elicin

FRONTIERS IN ONCOLOGY (2019)

Review Oncology

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)

Olgun Elicin, Paul Martin Putora, Marco Siano, Martina A. Broglie, Christian Simon, Daniel Zwahlen, Gerhard F. Huber, Giorgio Ballerini, Lorenza Beffa, Roland Giger, Sacha Rothschild, Sandro Negri, Pavel Dulguerov, Guido Henke

FRONTIERS IN ONCOLOGY (2019)

Review Oncology

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)

Martina A. Broglie, Pavel Dulguerov, Guido Henke, Marco Siano, Paul Martin Putora, Christian Simon, Daniel Zwahlen, Gerhard F. Huber, Giorgio Ballerini, Lorenza Beffa, Roland Giger, Sacha Rothschild, Sandro Negri, Olgun Elicin

FRONTIERS IN ONCOLOGY (2019)

Review Oncology

A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)

Marco Siano, Pavel Dulguerov, Martina A. Broglie, Guido Henke, Paul Martin Putora, Christian Simon, Daniel Zwahlen, Gerhard F. Huber, Giorgio Ballerini, Lorenza Beffa, Roland Giger, Sacha Rothschild, Sandro Negri, Olgun Elicin

FRONTIERS IN ONCOLOGY (2019)

Article Oncology

Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort

Sabine Schmid, Laetitia A. Mauti, Alex Friedlaender, Veronika Blum, Sacha I. Rothschild, Hasna Bouchaab, Patrizia Frosch, Christian Britschgi, David Konig, Luciano Wannesson, Wolf-Dieter Janthur, Sami Schar, Izadora Demmer, Alfredo Addeo, Wolfram Jochum, Martin Fruh

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Article Oncology

Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer

Marta Trub, Franziska Uhlenbrock, Christina Claus, Petra Herzig, Martin Thelen, Vaios Karanikas, Marina Bacac, Maria Amann, Rosemarie Albrecht, Claudia Ferrara-Koller, Daniela Thommen, Sacha Rothschield, Spasenija Savic Prince, Kirsten D. Mertz, Gieri Cathomas, Robert Rosenberg, Viola Heinzelmann-Schwarz, Mark Wiese, Didier Lardinois, Pablo Umana, Christian Klein, Heinz Laubli, Abhishek S. Kashyap, Alfred Zippelius

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Meeting Abstract Oncology

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17)

Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, Martina Schneider, Julian Andreas Schardt, Roland Seiler, Andreas Erdmann, Sacha Rothschild, Stefanie Aeppli, Nicolas Mach, Raeto Strebel, Boris A. Hadaschik, Dominik R. Berthold, Miklos Pless, Deborah Zihler, Mathias Schmid, Christine Biaggi Rudolf, Martin Spahn

JOURNAL OF CLINICAL ONCOLOGY (2020)

Meeting Abstract Oncology

TCR-beta repertoire convergence and evenness are associated with response to immune checkpoint inhibitors

P. Jermann, K. Leonards, T. Looney, I. Alborelli, S. I. Rothschild, S. Savic Prince, K. Mertz, A. Zippelius, L. Bubendorf

ANNALS OF ONCOLOGY (2019)

Meeting Abstract Oncology

Crizotinib in patients with advanced or metastatic ROS1-rearranged lung cancer (EUCROSS): A European phase II clinical trial-Updated report on progression-free and overall survival.

Sebastian Yves Friedrich Michels, Jeremy Franklin, Bartomeu Massuti, Martin Sebastian, Hans-Ulrich Schildhaus, Enriqueta Felip, Christian Grohe, Delvys Rodriguez-Abreu, Helge Bischoff, Enric Carcereny, Jesus Corral, Anne-Marie C. Dingemans, Amelia Insa, Martin Reck, Sacha Rothschild, Egbert F. Smit, Mariano Provencio, Reinhard Buttner, Rafael Rosell, Juergen Wolf

JOURNAL OF CLINICAL ONCOLOGY (2019)

Editorial Material Medicine, General & Internal

Oncology - Modern Diagnostics and Therapy

Sacha Rothschild, Alfred Zippelius

THERAPEUTISCHE UMSCHAU (2019)

Meeting Abstract Oncology

Incidence of hypocalcemia in patients with metastatic breast cancer under treatment with denosumab: A non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab administered every 4 weeks versus every 12 weeks: SAKK 96/12 (REDUSE)

A. Mueller, A. J. Templeton, S. Hayoz, H. Hawle, U. Hasler-Strub, M. Schwitter, B. C. Pestalozzi, O. Pagani, P. Butzberger, T. Wehrhahn, D. Rauch, R. Inauen, D. Betticher, K. Zaman, A. Bodmer, R. A. Popescu, S. Rothschild, J. Schardt, M. Borner, A. Fuhrer, C. Schar, S. Gillessen, R. von Moos

CANCER RESEARCH (2019)

Meeting Abstract Oncology

Tumor mutational burden assessed by a targeted NGS assay predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer

P. Jermann, I. Alborelli, K. Leonards, S. I. Rothschild, L. Leuenberger, S. Savic Prince, K. Mertz, S. Poechtrager, A. Zippelius, L. Quagliata, L. Bubendorf

ANNALS OF ONCOLOGY (2019)

暂无数据